EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Advances in Drug Delivery Systems Based on Red Blood Cells and Their Membrane-Derived Nanoparticles

Phuong Hoang Diem Nguyen iD, Migara Kavishka Jayasinghe, Anh Hong Le iD, Boya Peng iD, Minh T N Le iD

ACS Nano · 28.03.2023 · 17 (6) · 5187-5210

DOI: 10.1021/acsnano.2c11965 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ACS Nano, online erschienen am 10.03.2023. Verfasst von Phuong Hoang Diem Nguyen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, and Institute for Digital Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117600, …. Hauptthemen laut MEDLINE: Drug Delivery Systems, Nanoparticles. Die Arbeit wurde bisher 235-mal zitiert (Crossref) und nennt 192 Literaturangaben. Gefördert von: Ministry of Education - Singapore, Ministry of Health -Singapore, National University of Singapore.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Red blood cells (RBCs) and RBC membrane-derived nanoparticles have been historically developed as bioinspired drug delivery systems to combat the issues of premature clearance, toxicity, and immunogenicity of synthetic nanocarriers. RBC-based delivery systems possess characteristics including biocompatibility, biodegradability, and long circulation time, which make them suited for systemic administration. Therefore, they have been employed in designing optimal drug formulations in various preclinical models and clinical trials to treat a wide range of diseases. In this review, we provide an overview of the biology, synthesis, and characterization of drug delivery systems based on RBCs and their membrane including whole RBCs, RBC membrane-camouflaged nanoparticles, RBC-derived extracellular vesicles, and RBC hitchhiking. We also highlight conventional and latest engineering strategies, along with various therapeutic modalities, for enhanced precision and effectiveness of drug delivery. Additionally, we focus on the current state of RBC-based therapeutic applications and their clinical translation as drug carriers, as well as discussing opportunities and challenges associated with these systems.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Delivery SystemsNanoparticlesDrug CarriersErythrocytesAdministration, Cutaneous

Stichwörter der Autor:innen

cell membranedrug deliveryextracellular vesicleshitchhikingnanoparticlespharmacokineticsred blood cellstherapeutics

Substanzen

Drug Carriers

Autor:innen und Institutionen

  • Department of Pharmacology, and Institute for Digital Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117600, Singapore.
  • Department of Surgery, Immunology Programme, Cancer Programme and Nanomedicine Translational Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117600, Singapore.

ORCID-Profile: Phuong Hoang Diem Nguyen, Anh Hong Le, Boya Peng, Minh T N Le

Förderung

  • Ministry of Education - Singapore
  • Ministry of Health -Singapore
  • National University of Singapore

Zitieren

APA

Nguyen, P. H. D., Jayasinghe, M. K., Le, A. H., Peng, B., & Le, M. T. N. (2023). Advances in Drug Delivery Systems Based on Red Blood Cells and Their Membrane-Derived Nanoparticles. ACS Nano, 17(6), 5187-5210. https://doi.org/10.1021/acsnano.2c11965

Vancouver

Nguyen PHD, Jayasinghe MK, Le AH, Peng B, Le MTN. Advances in Drug Delivery Systems Based on Red Blood Cells and Their Membrane-Derived Nanoparticles. ACS Nano. 2023;17(6):5187-5210. doi:10.1021/acsnano.2c11965

BibTeX
@article{Nguyen2023,
  author = {Nguyen, Phuong Hoang Diem and Jayasinghe, Migara Kavishka and Le, Anh Hong and Peng, Boya and Le, Minh T N},
  title = {Advances in Drug Delivery Systems Based on Red Blood Cells and Their Membrane-Derived Nanoparticles},
  journal = {ACS Nano},
  year = {2023},
  volume = {17},
  number = {6},
  pages = {5187--5210},
  doi = {10.1021/acsnano.2c11965}
}
Kostenlos starten →